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SUPPLEMENTARY MATERIALS AND METHODS 
 
EdU staining and flow cytometry 
G1/S-arrested cells were incubated with 10 µM EdU (5-ethynyl-2´-deoxyuridine) (ThermoFisher) 
for 30 min before release into fresh medium. Harvested cells were fixed with 4 % 
paraformaldehyde at RT for 15 min, permeabilized by saponin-based permeabilization buffer 
(ThermoFisher) for 15 min, and subjected to EdU-click reaction using Alexa Fluor 488 picolyl 
azide and click-iT Plus EdU flow cytometry assay kit (ThermoFisher) according to the 
manufacturer’s protocol. Cells were washed once and resuspended with 200 µg/mL PureLinkTM 
RNase A and eBioscienceTM 7-AAD viability staining solution (ThermoFisher). After 30 min 
incubation at 37 °C, cells were analyzed with the Attune NxT acoustic focusing cytometer and 
the Attune NxT software v2.7 (ThermoFisher).  
 
Fluorescence microscopy for GFP-Pol η foci detection 
Cells were reverse-transfected onto coverslips with GFP-Pol η, and after 24 h, UVC irradiated 
with 40 J/m2. Where indicated, cells were pre-incubated with 10 µM EdU for 30 min to mark S-
phase cells. After 2 h recovery time, coverslips were fixed for 10 min at 4 °C using 4% 
paraformaldehyde. Cells were then permeabilized using PBS/0.3% Triton X-100 for 3 min at 
4 °C. After quickly blocking coverslips with 1% BSA, EdU-click reaction was performed with 
Alexa Fluor 647 picolyl azide using Click-iT Plus EdU Imaging kits (ThermoFisher) according to 
the manufacturer’s protocol. After another 1 % BSA blocking step, cells were  incubated with 
1:300 anti-GFP (B-2) for 2 h at RT and, after washing with PBS, with 1:1000 Alexa Fluor 488 
goat anti-mouse IgG for 45 min in 1 % BSA. After washing again with PBS, coverslips were 
mounted using DAPI-containing mounting medium (Vector Lab) and analyzed with either the 
Leica TCS SP8 X confocal microscope or the Nikon Eclipse Ts2R inverted microscope. For 
GFP epifluorescence, MSCV-transduced cells were fixed with 4% paraformaldehyde for 10 min 
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at 4 °C, washed three times with PBS and mounted with DAPI-containing mounting medium 
(Vector Lab).  
 
RT-qPCR 
RNA was isolated using TRIzol (Invitrogen) and chloroform (Sigma). cDNA synthesis was 
performed using a high-capacity cDNA reverse transcription kit (Applied Biosystems) according 
to the manufacturer’s protocols. Real-time quantitative PCR was performed using Fast SYBR 
Green Master Mix (Applied Biosystems) and a StepOnePlus Real-Time PCR system (Applied 
Biosystems). GAPDH mRNA levels were used as a control for normalization. The following 
primers were used for cDNA amplification: ETAA1 forward 5′-TCCTTGTACTCCCAGTGTAG-3′; 
ETAA1 reverse 5′-TTGAATCACATCTAGCTCTTCC-3′. 
 
Chromatin extraction 
Cells were lysed using lysis (S) buffer (10 mM HEPES pH 7.4, 10 mM KCl, 0.05% NP-40) for 20 
min on ice. After centrifugation at 14,000 rpm for 10 min, nuclei were lysed with low salt buffer 
(10 mM Tris-HCl pH 7.5, 0.2 mM MgCl2 + 1% Triton X-100) for 15 min on ice. After 
centrifugation at 14,000 rpm for 10 min, the pellet containing chromatin were resuspended with 
chromatin buffer 0.2 N HCl and incubated for 20 min on ice. The supernatant was neutralized 
with 1 M Tris-HCl pH 8.0.  
 
CRISPR/Cas9 gene editing 
A pair of oligos containing the human UBR1 sgRNA targeting sequence were designed from 
crispr.mit.edu. The forward oligo sequence is 5′-CACCGTGAGAGGATGGAAATCAGCG-3′ and 
the reverse oligo sequence is 5′-AAACCGCTGATTTCCATCCTCTCAC-3′. Annealed oligos 
were cloned into pSpCas9(BB)-2A-Puro (pX459; a gift from Feng Zhang, Addgene plasmid 
#48139 (Ran et al., 2013)) and transfected into U2OS cells using GeneJuice  (Millipore). Control 
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cells were transfected with a pX459 empty vector. Twenty-four hours after transfection, cells 
were selected with 2 µg/mL puromycin. After recovery from selection, cells were seeded onto 
96-well plates, in medium without puromycin, for clonal selection. Selected clones were 
subsequently analyzed by Western blotting, using anti-UBR1 antibody, to confirm successful 
knockout.  
 
3D modeling  
All molecular modeling was done in UCSF Chimera, production version 1.12 (build 41623) 
(Pettersen et al., 2004). The receptor protein was generated by removing the ligand from PDB 
3NY3, a structure of the UBR-box of UBR2 interacting with the N-degron Arg-Ile-Phe-Ser, 
solved by X-ray diffraction. For docking, a .pdb file of the receptor protein was uploaded to the 
online docking server ClusPro 2.0 and run in Peptide Mode. The peptide sequence KGGFG 
(searched using motif KXG[FY]G) was docked using default settings, resulting in 129 results. 
From those, all models that did not have hydrogen bonds between the ligand and either D150 or 
D153 of the receptor were eliminated, reducing the number of potential models to 12. These 
residues were determined to be important based on the hydrogen bonds made between them 
and the native ligand in the source file (3NY3). Each model was then manually checked for 
positional similarity to the native ligand of 3NY3, with only 4 models that reasonably aligned to 
the position of the native ligand. Next, solvent-excluded molecular surface maps of the receptor 
and the ligands were generated within Chimera using the MSMS package, and model 001.048 
was chosen as the final model based on best fit into the receptor pocket. This model was from 
the pool of results generated using the algorithm for biasing toward van der Waals and 
electrostatic interactions. Additionally, model 001.048 had the best hydrogen-bonding network, 
making two bonds from the lysine to D153 and one to D150, while the other models only had 
one hydrogen bond to each residue or fewer. For the final model, the receptor without any 
ligands was charged and energy-minimized and the chosen ligand then added. Hydrogen bonds 
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were calculated through Chimera using the default settings. To calculate the electrostatic 
surface potential of the receptor protein, the PDB2PQR and energy minimization tools within 
Chimera were used with default settings to add hydrogens and assign charges and atomic radii, 
using the forcefields AMBER ff14SB with the AM1-BCC option for non-standard residues. APBS 
was used from within Chimera with default settings to generate a .dx potential file. This file was 
used to color the MSMS surface map according to electrostatic potential. 
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Supplementary Table S1. siRNA oligo information used in this study 
 
 
 
 
 
Gene Sequence Manufacturer Catalog # 
Control CAGGGTATCGACGATTACAAA Qiagen SI03650318 
ETAA1 GCAUGUCAUCAAUUAGAUAtt Ambion s29018 
NPL4 AACAGCCtCCTCCAACAAATC Qiagen Custom 
p97-1 AAGATGGATCtCATTGACCTA Qiagen SI03019681 
p97-2 AACAGCCATTCtCAAACAGAA Qiagen SI03019730 
p97-3 AAACAGAUCCUAGCCCUUA Dharmacon D-008727-06-0005 
SDE2-1 AAACGGCAATGGCCTACTAAA Qiagen SI03121503 
TOPBP1 GGAUAUAUCUUUGCGGUUUtt Ambion s21823 
UBR1-1 AAGCAGGAGGAAAGTGTACAA Qiagen Custom  
UBR1-2 ATGGAAATCAGCGCGGAGTTA Qiagen Custom 
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Supplementary Table S2. Antibody information used in this study 
 
Antigen Manufacturer Catalog Number 
BrdU (BU1/75 ICR1) for CldU Abcam Cat# ab6326 
BrdU (B44) for IdU BD Cat# 347580 
C1orf55 (SDE2) Sigma Atlas Cat# HPA031255 
CDT1 Cell Signaling Cat# 3386 
CHK1 (G-4) Santa Cruz Cat# sc-8408 
pCHK1 (S317) Cell Signaling Cat# 2344 
pCHK1 (S345) Cell Signaling Cat# 2341 
Flag M2 Sigma Cat# F1804 
GFP (B-2) Santa Cruz Cat# sc-9996 
GFP (JL-8) Clontech Cat# 632381 
GFP Abcam Cat# Ab6556 
HA (6E2) Cell Signaling Cat# 2367 
Histone H4 Millipore Cat# 07-108 
HSC70 Santa Cruz Cat# sc-7298 
MCM6 (H-8) Santa Cruz Cat# sc-393618 
NPL4 Bethyl Cat# A304-102A 
p97 Cell Signaling Cat# 2648 
PCNA (PC-10) Santa Cruz Cat# sc-56 
RAD18 (3H7) Abcam Cat# ab57447 
RPA32 Millipore Cat# NA19L 
pRPA32 (Ser33) Bethyl Cat# A300-246A 
pSDE2 (T319)  Custom from Genscript Antigen: TETEE(pT)QEKKAC 
TOPBP1 Bethyl Cat# A300-111A 
Tubulin Bethyl Cat# A302-631A 
Ubiquitin (P4D1) Cell Signaling Cat# 3936 
UBR1 Bethyl Cat# A302-988A 
UBR2 Bethyl Cat# A305-416A 
UBXN7 Bethyl Cat# A303-865A 
UFD1 Bethyl Cat# A301-875A 
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Supplementary Table S3. Chemical information used in this study 
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Name Manufacturer Catalog Number 
BrdU Sigma Cat# B5002 
Camptothecin (CPT) ThermoFisher Cat# A10044 
CldU Sigma Cat# C9911 
Cycloheximide Sigma Cat# C6891 
Doxycycline Sigma Cat# C4859 
EdU Sigma Cat# D9891 
Hydroxyurea Crystallin (HU) Sigma Cat# H8627 
IdU Sigma Cat# I7125 
MG132 Sigma Cat# C2211 
Mitomycin C Sigma Cat# M0503 
NMS-873 Selleckchem Cat# S7285 
Puromycin Sigma Cat# P8833 
Thymidine Sigma Cat# T1895 
VE-821 Selleckchem Cat# S8007 
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Supplementary Figure S1. Characterization of SDE2Ct as an Arg/N-end rule substrate 
(Related to Figure 1) 
 
(A) The mammalian Arg/N-end rule pathway. The N-end rule determines the in vivo half-life of a 
protein based on the identity of its N-terminal residue (N-degron), identified as a degradation 
signal, and mostly exposed following endolytic cleavage. Modification of Asn or Gln via the N-
terminal amidases NTAN1 and NTAQ1, generating Asp and Glu, respectively, followed by 
arginylation mediated by the arginyltransferase 1 (ATE1) constitutes the tertiary, secondary, and 
primary degrons, respectively. Their primary degrons, together with other positively charged 
type 1 residues, such as Lys (marked in a light green circle in the case of SDE2Ct) are 
recognized by the UBR box-containing ubiquitin E3 ligase UBRs (also called N-recognins) for 
polyubiquitination and proteasome delivery. C* denotes oxidized N-terminal Cys caused by nitric 
oxide (NO) and oxygen. (B) Quantification of the immunoblot intensity of SDE2Ct WT or GA (C) 
Quantification of the immunoblot intensity of SDE2Ct WT or K78V (D) U2OS cells expressing 
wild-type (WT) or K78A full-length SDE2-Flag were treated with 50 µg/mL cycloheximide (CHX) 
or DMSO (vehicle) for the indicated times and analyzed by Western blotting (WB). (E) WB of 
U2OS cells transiently expressing WT, K78V, or G76A/G77A SDE2-Flag. EV: empty vector (F) 
Quantification of the immunoblot intensity of SDE2Ct-Flag or HA-SDE2Ct (G) U2OS cells 
expressing the WT or K94R SDE2-Flag were treated with DMSO or 10 µM of the proteasome 
inhibitor MG132 for 6 h and subsequently analyzed by WB. For (B), (C), and (F), data are mean 
± SD from two independent experiments., * p < 0.05, Student’s t-test. Immunoblot intensities 
were normalized by loading controls.  
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Supplementary Figure S2. Characterization of UBR1 and UBR2 as ubiquitin E3 ligases 
involved in SDE2Ct degradation (Related to Figure 2) 
 
(A) U2OS cells sequentially transfected with the indicated siRNA oligos (vs. control: CTL) and 
full-length SDE2-Flag were treated with 50 µg/mL CHX for the indicated times, and SDE2Ct-Flag 
levels were analyzed by WB. SDE2Ct levels were normalized by loading control and quantitated 
by ImageJ (0 h set as 100 %). (B) Quantification of endogenous SDE2Ct levels of Fig. 2C from 
two independent experiments. * p < 0.05, Student’s t-test.(C) Quantification of the SDE2Ct 
immunoblot intensity of Fig. 2D from two independent experiments. * p < 0.05, WT vs. Ubr1/2-/-, 
unpaired two-tailed t-test. (D) Schematic of the UBR1 knockout strategy in U2OS cells using 
CRISPR/Cas9. The 20-nucleotide sgRNA target locus on exon 1 is delineated with a blue line, 
along with the PAM sequence delineated as a red line. The cleavage site for the Cas9 nuclease 
is indicated by a red triangle. (E) U2OS control (WT) or UBR1-/- clones were first transfected with 
either control or UBR2 siRNA oligos, then SDE2-Flag expression plasmid. Three hours after 
treatment with 50 µg/mL (CHX) or DMSO, SDE2Ct-Flag levels were analyzed by WB. (F) Anti-
Flag co-immunoprecipitation (IP) of 293T cells co-expressing GFP-UBR1 and SDE2-Flag after 
40 J/m2 UVC or mock treatment. (-) indicates empty vector transfection.  
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Supplementary Figure S3. Damage-dependent SDE2Ct degradation after UVC-induced 
replication stress (Related to Figure 3) 
 
(A) U2OS cells expressing empty vector or SDE2-HA were irradiated or not with 40 J/m2 UVC, 
and 4 h later, cell lysates were fractionated, and endogenous SDE2Ct and exogenous SDE2Ct-
HA levels were analyzed by WB. (B) U2OS cells transfected with N-terminally Flag-tagged 
SDE2Ct (i.e. Flag-SDE2 ΔUBL) wild-type or ΔSAP were fractionated into cytoplasmic (S), 
nucleoplasmic (P1), and chromatin (P2) fractions, and each fraction was analyzed by WB. (C-F) 
Quantification of the SDE2Ct immunoblot intensities in the P fractions of Fig. 3A (S3C), Fig. 3B 
(S3D), Fig. 3C (S3E), and Fig. 3D (S3F) from two independent experiments. * p < 0.05, ** p < 
0.01, unpaired two-tailed t-test. (G) U2OS cells expressing N-terminally GFP-tagged SDE2 were 
transfected with both UBR1 and UBR2 siRNA oligos (vs. CTL), irradiated with 40 J/m2, and 4 h 
later, cell lysates were fractionated and SDE2Ct levels were analyzed by WB. (H) U2OS cells 
were transfected with indicated combination of siRNA oligos and GFP-SDE2, irradiated with 40 
J/m2 UVC, and P fractions were analyzed by WB (UBR2 blot from S fraction). (I) U2OS cells 
transfected with RAD18 siRNA (vs. CTL) were irradiated with 40 J/m2 UVC, fractionated into S 
and P fractions, and analyzed by WB.  	
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Supplementary Figure S4. Characterization of the p97 adapters required for SDE2Ct 
degradation (Related to Figure 4).  
 
(A) Quantification of the SDE2Ct immunoblot intensity of Fig. 4A from two independent 
experiments. * p < 0.05, unpaired two-tailed t-test. (B) U2OS cells expressing Nt GFP-tagged 
SDE2 or Ct Flag-tagged SDE2 were UVC irradiated, let recover for 4 h, and P fractions were 
analyzed by WB. Where indicated, cells were pretreated with 10 µM NMS-873 for 1 h. * 
nonspecific. (C) U2OS cells transfected with indicated with siRNA oligos were irradiated or not 
with 40 J/m2 UVC, and 4 h later, cell lysates were fractionated, and P fractions were analyzed 
by WB. (D) Quantification of SDE2Ct-Flag levels of Fig. 4D from three independent experiments. 
* p < 0.05, ** p < 0.01, unpaired two-tailed t-test (E) U2OS cells expressing SDE2-Flag WT or 
T319A were irradiated with 40 J/m2 UVC, and recovered for 2 h. Chromatin fractions were 
subjected to anti-Flag IP and WB with anti-pSDE2 T319 and Flag antibodies. (F) U2OS cells 
expressing SDE2-Flag was pretreated with 10 µM ATR inhibitor (VE-821) for 1 h, irradiated with 
50 J/m2 UVC, and after 2 h, P fractions were subjected to anti-Flag IP and WB. Fold increase 
average was quantitated from two independent experiments. (G) 293T cells expressing SDE2-
Flag were irradiated with 50 J/m2 UVC (2 h recovery with 20 µM MG132), and whole cell lysates 
were treated with lambda phosphatase at 30 °C for 30 min. pRPA32 serves as a control for 
phosphatase treatment. (H) 293T cells transfected with indicated plasmids were pretreated with 
10 µM VE-821 (ATR inhibitor) for 1 h, UVC irradiated and let recover for 2 h in the presence of 
the inhibitor. Cell lysates were analyzed by anti-Flag IP and WB. (I) 293T cells transfected with 
indicated plasmids were subjected to anti-Flag IP and WB.  
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Supplementary Figure S5. SDE2Ct degradation upon replication stress promotes RPA 
phosphorylation (Related to Figure 5) 
 
(A) SDE2 WT or K78V flipped cells by siRNA and doxycycline (dox) induction were incubated 
with 2 mM HU for 18 h and released for the indicated times, followed by WB. As: asynchronous. 
(B) U2OS K78V SDE2-HA Flp-In cells were treated or not with 10 ng/mL dox for 48 h to induce 
the expression of the K78V mutant (on endogenous SDE2 background) prior to treatment with 2 
mM hydroxyurea (HU) for 20 h. Cells were then released into fresh medium for the indicated 
times before WB analysis. (C) U2OS cells transduced with the indicated siRNA-resistant (siR) 
WT or mutant SDE2-Flag using the Murine Stem Cell Virus (MSCV) retroviral vectors were 
analyzed by WB following puromycin selection. (D) U2OS cells stably expressing WT or K78V 
SDE2-Flag (MSCV) were transfected with SDE2 siRNA oligos, then irradiated or not (0 h) with 
10 J/m2 UVC, and harvested at the indicated times for WB analysis. (E) SDE2 siRNA-
transfected U2OS cells stably expressing WT or K78V SDE2-Flag (MSCV) were irradiated or 
not with 10 J/m2 UVC, and 4 h later, cell lysates were fractionated and analyzed by WB for the 
localization of phosphorylated RPA. (F) U2OS cells transiently expressing K78V or ΔSAP 
SDE2-Flag (vs. empty vector) were irradiated or not (0 h) with 10 J/m2 UVC, and harvested at 
the indicated times to examine the suppression of RPA phosphorylation by the SDE2 mutants. 
(G) Analysis of cycling cells (MSCV) at S phase by EdU/7-ADD staining and flow 
cytometry.Mean ± SD (n=3 independent experiments), n.s. not significant. (H) (Left) siRNA-
transfected U2OS cells were treated with 100 nM CPT, and cell lysates were analyzed by WB. 
(Right) confirmation of ETAA1 knockdown by RT-qPCR. Experiments were performed in 
triplicates, and error bar indicates mean ± SD from three independent experiments.  
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Supplementary Figure S6. SDE2Ct degradation upon UVC-induced replication stress is 
required for DNA damage bypass signaling (Related to Figure 6) 
 
(A) U2OS cells stably expressing WT or K78V SDE2-Flag WT or K78V (MSCV) were 
transfected with SDE2 siRNA oligos, incubated with 10 µM BrdU for 48 h, and irradiated with 40 
J/m2 UVC. Two hours later, coverslips were fixed and processed for anti-BrdU 
immunofluorescence in non-denaturing conditions. Representative images demonstrate that 
ssDNA formation, as revealed by BrdU immunofluorescence, is reduced in the K78V-expressing 
cells. Scale bar, 10 µm. (B) Quantification of BrdU fluorescence intensity from (A) using Image 
J. A representative result from two independent experiments is shown. *p < 0.0001, two-tailed 
unpaired Student’s t-test. (C) Quantification of the RAD18 immunoblot intensity of Fig. 6C 
normalized by PCNA from two independent experiments. (D) SDE2 siRNA-transfected U2OS 
cells stably expressing WT or K78V SDE2-Flag (MSCV) were irradiated with 40 J/m2 UVC, 
fractionated, and cell lysates were analyzed by WB for pRPA, RAD18 recruitment, and PCNA 
monoubiquitination. (E) U2OS cells transiently expressing K78V SDE2-Flag were left untreated 
or irradiated with 10 J/m2 UVC, and 6 h later, cell lysates were fractionated and analyzed by WB 
for PCNA monoubiquitination. (F) Representative images GFP-Pol η from EdU- cells in Figure 
6D. Scale bar, 10 µm. (G) (Left) siRNA-transfected U2OS cells stably expressing WT or K78V 
SDE2-Flag (MSCV) were transiently expressed with GFP-pol η, irradiated with 40 J/m2 UVC, 
and 4 h later, cell were fixed and GFP-Pol η focus formation was examined by GFP 
epifluorescence. Representative images are shown. Scale bar, 5 µm. (Right) quantification of 
GFP-Pol η foci using ImageJ(foci+ indicates more than 20 defined GFP-Pol η foci). Mean ± 
SEM (n=2). * p = 0.0043, unpaired Student’s t-test. (H) siRNA-transfected U2OS cells were 
irradiated with 40 J/m2 UVC, and 4 h later, cell lysates were analyzed by WB. (I) Distribution of 
IdU track length from ongoing forks of WT or K78V Flp-In cells (dox-induced and knocked-
down) from Figure6G. A representative graph from three independent experiments is shown. (J) 
Plotting of IdU track length from (I). n.s. not significant, Mann-Whitney test. 
